Marshall Wace, LLP Pds Biotechnology Corp Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Marshall Wace, LLP holds 28,187 shares of PDSB stock, worth $47,072. This represents 0.0% of its overall portfolio holdings.

Number of Shares

28,187

Holding current value

$47,072

% of portfolio

0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.93 - $4.23 $82,587 - $119,231	28,187 New	28,187 $107,000
Q1 2024 May 15, 2024	BUY	$3.85 - $6.59 $158,700 - $271,646	41,221 New	41,221 $163,000
Q3 2023 Nov 14, 2023	SELL	$4.8 - $6.4 $21,240 - $28,320	-4,425 Reduced 6.04%	68,795 $347,000
Q2 2023 Aug 14, 2023	SELL	$5.03 - $9.9 $330,913 - $651,301	-65,788 Reduced 47.33%	73,220 $368,000
Q1 2023 May 15, 2023	BUY	$5.68 - $11.99 $587,175 - $1.24 Million	103,376 Added 290.12%	139,008 $854,000
Q4 2022 Feb 14, 2023	BUY	$3.28 - $13.2 $26,351 - $106,048	8,034 Added 29.11%	35,632 $470,000
Q3 2022 Nov 14, 2022	SELL	$2.97 - $5.79 $145,966 - $284,561	-49,147 Reduced 64.04%	27,598 $82,000
Q2 2022 Aug 15, 2022	SELL	$3.05 - $6.68 $285,888 - $626,143	-93,734 Reduced 54.98%	76,745 $281,000
Q1 2022 May 16, 2022	BUY	$4.78 - $8.43 $485,409 - $856,066	101,550 Added 147.33%	170,479 $1.06 Million
Q4 2021 Feb 14, 2022	BUY	$7.76 - $14.35 $83,466 - $154,348	10,756 Added 18.49%	68,929 $557,000
Q3 2021 Nov 15, 2021	BUY	$9.33 - $17.08 $542,754 - $993,594	58,173 New	58,173 $867,000
Q2 2021 Aug 13, 2021	SELL	$4.35 - $12.86 $192,409 - $568,823	-44,232 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.28 - $6.81 $100,848 - $301,219	44,232 New	44,232 $201,000

Others Institutions Holding PDSB

# of Institutions

Shares Held

4.32M

Call Options Held

253K

Put Options Held

70.4K

Vanguard Group Inc Valley Forge, PA

1.52M
Shares

$2.54 Million
0.0% of portfolio
Black Rock Inc. New York, NY

487K
Shares

$813,234
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

415K
Shares

$693,238
0.0% of portfolio
Inspirion Wealth Advisors, LLC

344K
Shares

$575,137
0.18% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

234K
Shares

$391,129
0.0% of portfolio

View Full List

About PDS Biotechnology Corp

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $47.5M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

More about PDSB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account